Cargando…

Nanocell targeting using engineered bispecific antibodies

There are many design formats for bispecific antibodies (BsAbs), and the best design choice is highly dependent on the final application. Our aim was to engineer BsAbs to target a novel nanocell (EnGeneIC Delivery Vehicle or EDV(TM)nanocell) to the epidermal growth factor receptor (EGFR). EDV(TM)nan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Taylor, Karin, Howard, Christopher B, Jones, Martina L, Sedliarou, Ilya, MacDiarmid, Jennifer, Brahmbhatt, Himanshu, Munro, Trent P, Mahler, Stephen M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2014
Materias:	Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4622061/ https://www.ncbi.nlm.nih.gov/pubmed/25523746 http://dx.doi.org/10.4161/19420862.2014.985952

Ejemplares similares

Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models
por: Alfaleh, Mohamed A., et al.
Publicado: (2017)

Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
por: Khan, Muhammad Babar, et al.
Publicado: (2021)

Nanocell COVID-19 vaccine triggers a novel immune response pathway producing high-affinity antibodies which neutralize all variants of concern
por: Gao, Steven Y., et al.
Publicado: (2023)

Bacterial minicells to the rescue: cyto‐Immunotherapy for the treatment of late stage cancers with minimal to no toxicity
por: Brahmbhatt, Himanshu, et al.
Publicado: (2021)

A First-Time-In-Human Phase I Clinical Trial of Bispecific Antibody-Targeted, Paclitaxel-Packaged Bacterial Minicells
por: Solomon, Benjamin J., et al.
Publicado: (2015)

Self-assembly of Deinococcus radiodurans supports nanocell scenario of life origin
por: Bernadotte, Alexandra, et al.
Publicado: (2017)

Targeted Doxorubicin Delivery to Brain Tumors via Minicells: Proof of Principle Using Dogs with Spontaneously Occurring Tumors as a Model
por: MacDiarmid, Jennifer A., et al.
Publicado: (2016)

Translational applications of microRNAs in cancer, and therapeutic implications
por: Kwok, Grace T., et al.
Publicado: (2017)

In silico analysis of hypoxia activated prodrugs in combination with anti angiogenic therapy through nanocell delivery
por: Meaney, Cameron, et al.
Publicado: (2020)

Engineering IgG-Like Bispecific Antibodies—An Overview
por: Krah, Simon, et al.
Publicado: (2018)

Doxorubicin-loading core-shell pectin nanocell: A novel nanovehicle for anticancer agent delivery with multidrug resistance reversal
por: Ouyang, Jiabi, et al.
Publicado: (2020)

Fc Engineering for Developing Therapeutic Bispecific Antibodies and Novel Scaffolds
por: Liu, Hongyan, et al.
Publicado: (2017)

Asymmetric Fc Engineering for Bispecific Antibodies with Reduced Effector Function
por: Escobar-Cabrera, Eric, et al.
Publicado: (2017)

Bispecific antibodies and their applications
por: Fan, Gaowei, et al.
Publicado: (2015)

The making of bispecific antibodies
por: Brinkmann, Ulrich, et al.
Publicado: (2017)

A Novel Totivirus Naturally Occurring in Two Different Fungal Genera
por: Khalifa, Mahmoud E., et al.
Publicado: (2019)

A Mechanically Transmitted DNA Mycovirus Is Targeted by the Defence Machinery of Its Host, Botrytis cinerea
por: Khalifa, Mahmoud E., et al.
Publicado: (2021)

Molecular Characterization of Two Totiviruses from the Commensal Yeast Geotrichum candidum
por: Khalifa, Mahmoud E., et al.
Publicado: (2023)

YEAST SURFACE DISPLAY OF FULL-LENGTH IGG FOR ENGINEERING MONOCLONAL AND BISPECIFIC ANTIBODIES
por: Jiang, Youwei
Publicado: (2023)

A 29-year-old woman with recurrent syncope
por: Ducas-Mowchun, Kaleigh, et al.
Publicado: (2023)

Une femme de 29 ans atteinte d’épisodes répétitifs de syncope
por: Ducas-Mowchun, Kaleigh, et al.
Publicado: (2023)

Design and Production of Bispecific Antibodies
por: Wang, Qiong, et al.
Publicado: (2019)

Bispecific Antibodies for Diagnostic Applications
por: Parashar, Archana, et al.
Publicado: (2011)

Bispecific Antibodies and Gene Therapy
por: Nettelbeck, Dirk M.
Publicado: (2011)

Engineering death resistance in CHO cells for improved perfusion culture
por: MacDonald, Michael A., et al.
Publicado: (2022)

Highlights of Antibody Engineering and Therapeutics 2019 in San Diego, USA: Bispecific Antibody Design and Clinical Applications
por: Zhu, Yong, et al.
Publicado: (2020)

Engineering Immune Cells for in vivo Secretion of Tumor-Specific T Cell-Redirecting Bispecific Antibodies
por: Blanco, Belén, et al.
Publicado: (2020)

Tethered-variable C(L) bispecific IgG: an antibody platform for rapid bispecific antibody screening
por: Kim, Hok Seon, et al.
Publicado: (2017)

Production of Native Bispecific Antibodies in Rabbits
por: Wang, Wei, et al.
Publicado: (2010)

Bispecific antibodies: design, therapy, perspectives
por: Sedykh, Sergey E, et al.
Publicado: (2018)

Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies
por: Husain, Bushra, et al.
Publicado: (2018)

Bispecific Antibodies in the Treatment of Hematologic Malignancies
por: Duell, Johannes, et al.
Publicado: (2019)

Bispecific Antibodies Progression in Malignant Melanoma
por: Tang, Juan, et al.
Publicado: (2022)

Bispecific Immunomodulatory Antibodies for Cancer Immunotherapy
por: Blanco, Belén, et al.
Publicado: (2021)

Marine Biodiversity of Aotearoa New Zealand
por: Gordon, Dennis P., et al.
Publicado: (2010)

Clearance of amyloid‐beta with bispecific antibody constructs bound to erythrocytes
por: Taylor, Ronald P., et al.
Publicado: (2020)

Taking OAB seriously: A qualitative evaluation of primary care education on overactive bladder syndrome management
por: Turell, Wendy, et al.
Publicado: (2020)

Targeted cancer immunotherapy via combination of designer bispecific antibody and novel gene-engineered T cells
por: Urbanska, Katarzyna, et al.
Publicado: (2014)

Engineering a Novel Antibody-Peptide Bispecific Fusion Protein Against MERS-CoV
por: Wang, Lili, et al.
Publicado: (2019)

Structural design of tetravalent T-cell engaging bispecific antibodies: improve developability by engineering disulfide bonds
por: Yu, Lin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pum05obh6s8d84qlaqce56bm3s